Product Image

Flush-Free Niacin 500 mg

Bluebonnet
4.7
★ ★ ★ ★ ★
(118 ratings)
Niacin 500 mg
Product Image
Score76
A transparent flush-free niacin option with good tolerability, but weaker evidence for lipid effects and little direct skin value.
How scoring works
Quantity:120 Capsule(s) • (120 servings)
Goals:
Heart Health
Cardiovascular Support

Score 76

A transparent flush-free niacin option with good tolerability, but weaker evidence for lipid effects and little direct skin value.
How scoring works
$30.80($0.25 per serving)
iHerb
$ 30.80
Daily Vita
$ 30.80
Report prices

Analysis

Inositol hexanicotinate is a specialized niacin form intended to reduce the classic flushing response. The active and inositol amounts are clearly stated in a simple capsule.

The derivative does not reliably reproduce the lipid effects of nicotinic acid. It also lacks the direct skin-barrier positioning of niacinamide and adds no complementary heart or skin ingredients.

It fits people who specifically prioritize flush tolerance over pharmacologic lipid effects. Those managing cholesterol, liver disease, or diabetes should assess the high-dose product with a clinician.

Who is it for
  • Flush-sensitive niacin users
  • Adults seeking inositol hexanicotinate
  • People wanting a long-supply capsule
Best for
  • Low-flush vitamin B3 use
  • Specialized niacin-derivative supplementation
  • General cellular metabolism

Pros

  • Flush-free form is clearly named
  • Large supply
  • Simple formula

Cons

  • Less reliable lipid effect than nicotinic acid
  • Weak fit for skin support
  • Serving cost is only moderate

Warnings

  • People with liver disease should review regular high-dose use
  • High-dose niacin derivatives may affect glucose control in susceptible users
  • Do not treat flush-free niacin as equivalent to clinician-directed nicotinic acid therapy

Nutrient quality

76 High impact

Inositol hexanicotinate is a recognizable low-flush form with a substantial stated amount. Uncertain niacin release and weaker lipid-related performance limit the value of that dose.

Ingredient transparency

87 Highest impact

The active amount and serving size are clear, with no proprietary blend hiding the formula. Non-active ingredients and complete usage directions are not supplied.

Customer satisfaction

66 High impact

The average rating is very strong, with a moderate review count supporting the signal. No detailed reviews are supplied to assess repeated complaints or intended-use experiences.

Value for money

71 High impact

The long supply supports reasonable serving convenience. Uncertain niacin release and weaker lipid-related performance limit competitiveness at its premium positioning.

Report analysis

Goals

Heart Health
Heart Health
Impact
Moderate effect
D Goal FitB- Strength of SupportD- CoverageA Formula Quality

Flush-free niacin is less directly aligned with lipid management than nicotinic acid. The amount and chemical form are clearly disclosed.

The high amount may not reproduce the lipid effects associated with prescription-style niacin despite better flushing tolerance. High-dose niacin products can affect liver enzymes and glucose control in susceptible users.

Study evidence
Niacin Supportive 105 studies
Cardiovascular Support
Cardiovascular Support
Impact
Moderate effect
D Goal FitD Strength of SupportF CoverageA Formula Quality
Niacin · 500 mg

Niacin is relevant to lipid metabolism, but inositol hexaniacinate is a flush-free form with less reliable evidence for changing cardiovascular lipid markers than nicotinic acid. The substantial label amount therefore does not guarantee a comparable active niacin effect.

The simple formula is transparent and avoids unnecessary additions, yet its specialized form limits confidence in effective cardiovascular contribution. High-dose niacin forms can affect liver enzymes or glucose control, so people with liver disease or diabetes should discuss this amount with their clinician.

Study evidence
Niacin Supportive 136 studies

Ingredients

IngredientAmount per serving
Niacin (Inositol Hexaniacinate)
 500 mg
Inositol (Inositol Hexanicotinate)
 88 mg
Gluten Free Adults 18–50 Vegan Kosher Dairy Free Sugar Free No Allergies Vegetarian
Report overview
Niacin (Inositol Hexaniacinate) · 500 mg OverallScore82
B Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyC Value

The clearly identified inositol hexanicotinate form is designed to avoid the typical niacin flush and provides a substantial amount in one capsule. It may suit people prioritizing tolerability, though this form is less directly aligned with cardiovascular use than nicotinic acid. The serving cost offers fair value for a specialized flush-free form.

View ingredientView products
Loading alternative details
82 Performance

No Flush Niacin (Inositol Hexanicotinate) 800 mg

Life Extension
<p>Clearly named inositol hexanicotinate provides substantial flush-free niacin exposure with economical serving value. Compared with the original, it preserves the comfort-focused intent with a clearly identified and easier-to-assess vitamin B3 approach; however, its cardiovascular effects may be less direct and reliable than those of nicotinic acid.</p>
80 Performance

No Flush Niacin 500 mg

Natural Factors
<p>Transparent inositol hexaniacinate provides a substantial no-flush serving at practical cost. Compared with the original, it preserves the comfort-focused intent with a clearly identified and easier-to-assess vitamin B3 approach; however, the form may release niacin less directly than nicotinic acid and is not an equivalent lipid-focused option.</p>
80 Performance

No-Flush Niacin (Inositol Hexanicotinate) 500 mg

Solgar
<p>Clearly identified inositol hexanicotinate supports a comfort-focused no-flush approach with good serving value. Compared with the original, it preserves the comfort-focused intent with a clearly identified and easier-to-assess vitamin B3 approach; however, the form is less direct than nicotinic acid for cardiovascular purposes.</p>
86 Budget

Niacinamide B-3 100 mg

Source Naturals
<p>A clearly identified moderate niacinamide tablet offers simple non-flushing vitamin B3 support with excellent serving economics. Serving cost is lower than the original, but it does not provide nicotinic acid’s lipid-focused effects and complete excipient details are missing.</p>
82 Budget

Niacinamide 500 mg

NOW
<p>A simple niacinamide capsule provides clearly named non-flushing vitamin B3 with strong skin-goal alignment. Serving cost is lower than the original, but the amount remains high for routine nutrition and does not offer nicotinic acid’s lipid-related effects.</p>
80 Budget

Niacinamide 500 mg

Best Naturals
<p>Clearly identified niacinamide provides a non-flushing option with useful skin and NAD-metabolism alignment. Serving cost is lower than the original, but the amount is well above basic nutritional needs and is not equivalent to nicotinic acid for lipid-focused use.</p>
73 Value

No-Flush Niacin 500 mg

Source Naturals
<p>Inositol hexanicotinate offers a clearly identified flush-free vitamin B3 approach. Its lower serving cost and clearer active design support practical value compared with the original, although the released niacin amount and lipid-related benefit are less certain than with nicotinic acid.</p>
79 Value

Niacin Inositol Hexanicotinate 500 mg

Nature's Bounty
<p>Named inositol hexanicotinate provides substantial no-flush vitamin B3 exposure in a simple capsule. Its lower serving cost and clearer active design support practical value compared with the original, although its lipid-related effects may be less direct than nicotinic acid despite the practical serving cost.</p>
80 Value

Niacinamide

Thorne
<p>Clearly identified niacinamide provides a simple non-flushing option with strong skin-purpose alignment. Its lower serving cost and clearer active design support practical value compared with the original, although the amount is well above basic nutritional needs and is not a direct cardiovascular niacin substitute.</p>
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Niacinamide: A B vitamin that improves aging facial skin appearance.
    Bissett DL; Oblong JE; Berge CA · Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] · 2005
    Randomized trial50 participantsSkin Health forNiacin
  2. The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer.
    Hakozaki T; Minwalla L; Zhuang J; Chhoa M; Matsubara A; Miyamoto K; Greatens A; Hillebrand GG; Bissett DL; Boissy RE · The British journal of dermatology · 2002
    Randomized trial138 participantsSkin Health forNiacin
  3. Effect of Nicotinamide in Skin Cancer and Actinic Keratoses Chemoprophylaxis, and Adverse Effects Related to Nicotinamide: A Systematic Review and Meta-Analysis.
    Mainville L; Smilga AS; Fortin PR · Journal of cutaneous medicine and surgery · 2022
    Meta-analysis3,039 participants29 studies pooledSkin Health forNiacin
  4. Nicotinamide for Skin-Cancer Chemoprevention in Transplant Recipients.
    Allen NC; Martin AJ; Snaidr VA; Eggins R; Chong AH; Fernandéz-Peñas P; Gin D; Sidhu S; Paddon VL; Banney LA; Lim A; Upjohn E; Schaider H; Ganhewa AD; Nguyen J; McKenzie CA; Prakash S; McLean C; Lochhead A; Ibbetson J; Dettrick A; Landgren A; Allnutt KJ; Allison C; Davenport RB; Mumford BP; Wong B; Stagg B; Tedman A; Gribbin H; Edwards HA; De Rosa N; Stewart T; Doolan BJ; Kok Y; Simpson K; Low ZM; Kovitwanichkanont T; Scolyer RA; Dhillon HM; Vardy JL; Chadban SJ; Bowen DG; Chen AC; Damian DL · The New England journal of medicine · 2023
    Randomized trial158 participantsSkin Health forNiacin
  5. Evaluation of anti-wrinkle effects of a novel cosmetic containing niacinamide.
    Kawada A; Konishi N; Oiso N; Kawara S; Date A · The Journal of dermatology · 2008
    Randomized trial30 participantsSkin Health forNiacin
  6. A Foodborne Outbreak Traced to Niacin Overenrichment.
    Hudson PJ; Vogt RL · Journal of food protection · 2023
    Case-control study21 participantsSkin Health forNiacin
  7. Nicotinamide for Skin Cancer Chemoprevention.
    Breglio KF; Knox KM; Hwang J; Weiss R; Maas K; Zhang S; Yao L; Madden C; Xu Y; Hartman RI; Wheless L · JAMA dermatology · 2025
    Cohort study33,822 participantsSkin Health forNiacin
  8. Chemoprevention of keratinocyte carcinomas and actinic keratoses in adults who were immunocompetent: a systematic review.
    Susanto A; Morgan E; Lindsay D; Collins LG · Clinical and experimental dermatology · 2026
    Systematic review7,355 participants11 studies pooledSkin Health forNiacin
  9. The current state of niacin in cardiovascular disease prevention: a systematic review and meta-regression.
    Lavigne PM; Karas RH · Journal of the American College of Cardiology · 2013
    Meta-analysis9,959 participants11 studies pooledCardiovascular Support forNiacin
  10. Effects of niacin on apo A1 and B levels: a systematic review and meta-analysis of randomised controlled trials.
    Saboori S; Yousefi Rad E; Tammam J; Thondre PS; Coe S · The British journal of nutrition · 2024
    Meta-analysis12 studies pooledCardiovascular Support forNiacin
  11. Niacin improves lipid profile but not endothelial function in patients with coronary artery disease on high dose statin therapy.
    Philpott AC; Hubacek J; Sun YC; Hillard D; Anderson TJ · Atherosclerosis · 2013
    Randomized trial66 participantsCardiovascular Support forNiacin
  12. Relationship of lipoproteins to cardiovascular events: the AIM-HIGH Trial (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides and Impact on Global Health Outcomes).
    Guyton JR; Slee AE; Anderson T; Fleg JL; Goldberg RB; Kashyap ML; Marcovina SM; Nash SD; O'Brien KD; Weintraub WS; Xu P; Zhao XQ; Boden WE · Journal of the American College of Cardiology · 2013
    Randomized trial3,414 participantsCardiovascular Support forNiacin
  13. Supplemental Vitamins and Minerals for Cardiovascular Disease Prevention and Treatment: JACC Focus Seminar.
    Jenkins DJA; Spence JD; Giovannucci EL; Kim YI; Josse RG; Vieth R; Sahye-Pudaruth S; Paquette M; Patel D; Blanco Mejia S; Viguiliouk E; Nishi SK; Kavanagh M; Tsirakis T; Kendall CWC; Pichika SC; Sievenpiper JL · Journal of the American College of Cardiology · 2021
    Meta-analysisCardiovascular Support forNiacin
  14. Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: the ADMIT study: A randomized trial. Arterial Disease Multiple Intervention Trial.
    Elam MB; Hunninghake DB; Davis KB; Garg R; Johnson C; Egan D; Kostis JB; Sheps DS; Brinton EA · JAMA · 2000
    Randomized trial468 participantsCardiovascular Support forNiacin
  15. Effect of lipid-lowering therapies on lipoprotein(a) levels: a comprehensive meta-analysis of randomized controlled trials.
    Xie S; Galimberti F; Olmastroni E; Carugo S; Catapano AL; Casula M; META-LIPID Group · Atherosclerosis · 2025
    Meta-analysis145,314 participants147 studies pooledCardiovascular Support forNiacin
  16. Extended-release niacin vs gemfibrozil for the treatment of low levels of high-density lipoprotein cholesterol. Niaspan-Gemfibrozil Study Group.
    Guyton JR; Blazing MA; Hagar J; Kashyap ML; Knopp RH; McKenney JM; Nash DT; Nash SD · Archives of internal medicine · 2000
    Randomized trial173 participantsCardiovascular Support forNiacin
  17. Equivalent efficacy of a time-release form of niacin (Niaspan) given once-a-night versus plain niacin in the management of hyperlipidemia.
    Knopp RH; Alagona P; Davidson M; Goldberg AC; Kafonek SD; Kashyap M; Sprecher D; Superko HR; Jenkins S; Marcovina S · Metabolism: clinical and experimental · 1998
    Randomized trial223 participantsCardiovascular Support forNiacin
  18. Differential effect of two nicotinic acid preparations on low-density lipoprotein subclass distribution in patients classified as low-density lipoprotein pattern A, B, or I.
    Superko HR; McGovern ME; Raul E; Garrett B · The American journal of cardiology · 2004
    Randomized trial180 participantsHeart Health forNiacin
  19. The ARBITER 6-HALTS Trial (Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol 6-HDL and LDL Treatment Strategies in Atherosclerosis): final results and the impact of medication adherence, dose, and treatment duration.
    Villines TC; Stanek EJ; Devine PJ; Turco M; Miller M; Weissman NJ; Griffen L; Taylor AJ · Journal of the American College of Cardiology · 2010
    Randomized trial315 participantsHeart Health forNiacin
  20. The effects of extended-release niacin on carotid intimal media thickness, endothelial function and inflammatory markers in patients with the metabolic syndrome.
    Thoenes M; Oguchi A; Nagamia S; Vaccari CS; Hammoud R; Umpierrez GE; Khan BV · International journal of clinical practice · 2008
    Randomized trial50 participantsHeart Health forNiacin
  21. Effect of niacin therapy on cardiovascular outcomes in patients with coronary artery disease.
    Duggal JK; Singh M; Attri N; Singh PP; Ahmed N; Pahwa S; Molnar J; Singh S; Khosla S; Arora R · Journal of cardiovascular pharmacology and therapeutics · 2010
    Meta-analysis5,137 participants7 studies pooledHeart Health forNiacin
  22. Effect of niacin on endothelial function: a systematic review and meta-analysis of randomized controlled trials.
    Sahebkar A · Vascular medicine (London, England) · 2014
    Meta-analysis441 participants7 studies pooledHeart Health forNiacin